Sounds like the drug companies flexing pollical muscle i.e. via medicare, to keep their drug treatment, recurring cash flow going in the highest gear possiblee.
Hahahah funny - these Ellex/Nova eye bunnies had a great SLT for glaucoma treatment, proved VERY effective. Great laser bread & butter income & they sold it all to chase rainbows. All the $$ eaten up & a stick it to the LT holds shafting CR at 18c to get some more $$ to pay very average management salaries & fly around the world to conferences expenses.
All we can do is hope that iTrack advanced gets more market share now with FDA approval, than it has so far in all the countries it has been available for use for some time, with limited uptake & growth.
Getting taken off USA medicare re-imbursement sure wouldn't help BUT the drug companies would be happy.
https://glaucomatoday.com/articles/2022-jan-feb/cost-considerations-in-glaucoma-care
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807942/#:~:text=Since%20its%20approval%20by%20the,%E2%80%9330%25%2C%20on%20average.
https://www.google.com/search?q=ellex+slt+laser+for+glaucoma+treatment&rlz=1C1CHZN_enNZ947NZ947&oq=ellex+slt+laser+for+glaucoma+treatment&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIHCAEQIRigAdIBDjkyNjkzMzU0MGowajE1qAIAsAIA&sourceid=chrome&ie=UTF-8
Nova Eye Medical (EYE) Discussion, page-899
-
- There are more pages in this discussion • 2,289 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.79M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $38.96K | 239.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4819 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 79620 | 3 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |